An LC-MS/MS method for simultaneous determination of vincristine and verapamil in rat plasma after oral administration of a dual agent formulation

Biomedical Chromatography

Volumn 25, Issue 9, 2011, Pages 963-969

  Ling, Guixia ^a   Zhang, Peng ^a   Sun, Jin ^a   Zhang, Wenping ^a   Fu, Qiang ^a   Zhang, Tianhong ^a   Deng, Yihui ^a   He, Zhonggui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

HPLC MS MS; Plasma concentration; Verapamil; Vincristine

Indexed keywords

BODY FLUIDS; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; RATS;

HPLC-MS-MS; LC-MS-MS; ORAL ADMINISTRATION; PLASMA CONCENTRATION; RAPID METHOD; RAT PLASMA; SENSITIVE METHOD; SIMULTANEOUS DETERMINATIONS; VERAPAMIL; VINCRISTINE;

ELECTROSPRAY IONIZATION;

NANOPARTICLE; POLYGLACTIN; UNCLASSIFIED DRUG; VERAPAMIL; VERAPAMIL PLUS VINCRISTINE; VINCRISTINE;

ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY;

RATTUS;

EID: 79956313022     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1565     Document Type: Article

References (26)

1. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE and Gottesman MM. P-glycoprotein from genomics to mechanism. Oncogene 2003; 22(47): 7468-7485.
2. Bloemhof H, Van Dijk KN, De Graaf SS, Vendrig DE and Uges DR. Sensitive method for the determination of vincristine in human serum by high-performance liquid chromatography after on-line column-extraction. Journal of Chromatography 1991; 572(1-2): 171-179.
3. Borst P, Zelcer N, van de Wetering K and Poolman B. On the putative co-transport of drugs by multidrug resistance proteins. FEBS Letters 2006; 580(4): 1085-1093.
4. Botling J, Liminga G, Larsson R, Nygren P and Nilsson K. Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-kDa P-glycoprotein. International Journal of Cancer 1994; 58(2): 269-274.
5. Corona G, Casetta B, Sandron S, Vaccher E and Toffoli G. Rapid and sensitive analysis of vincristine in human plasma using on-line extraction combined with liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2008; 22(4): 519-525.
6. Dennison JB, Renbarger JL, Walterhouse DO, Jones DR and Hall SD. Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography/tandem mass spectrometry. Therapeutic Drug Monitoring 2008; 30(3): 357-364.
7. Embree L, Gelmon KA, Tolcher AW, Hudon NJ, Heggie JR, Dedhar C, Webb MS, Bally MB and Mayer LD. Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injection. Journal of Pharmaceutical and Biomedical Analysis 1997; 16(4): 675-687.
8. Guilhaumou R, Solas C, Rome A, Giocanti M, Andre N and Lacarelle B. Validation of an electrospray ionization LC/MS/MS method for quantitative analysis of vincristine in human plasma samples. Journal of Chromatography B 2010; 878(3-4): 423-427.
9. Hedeland M, Fredriksson E, Lennernäs H and Bondesson U. Simultaneous quantification of the enantiomers of verapamil and its N-demethylated metabolite in human plasma using liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 2004; 804(2): 303-311.
10. Hege HG. Gas chromatographic determination of verapamil in plasma and urine. Arzneimittelforschung 1979; 29(11): 1681-1684.
11. Ho EA, Soo PL, Allen C and Piquette-Miller M. Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors. Journal of Controlled Release 2007; 117(1): 20-27.
12. Horton JK, Thimmaiah KN, Houghton JA, Horowitz ME and Houghton PJ. Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts. Biochemical Pharmacology 1989; 38(11): 1727-1736.
13. Hynning PA, Anderson P, Bondesson U and Boréus LO. Liquid-chromatographic quantification compared with gas-chromatographic-mass-spectrometric determination of verapamil and norverapamil in plasma. Clinical Chemistry 1988; 34(12): 2502-2503.
14. Ivanova V, Zendelovska D, Stefova M and Stafilov T. HPLC method for determination of verapamil in human plasma after solid-phase extraction. Journal of Biochemical and Biophysical Methods 2008; 70(6): 1297-1303.
15. Jhee OH, Hong JW, Om AS, Lee MH, Lee WS, Shaw LM, Lee JW and Kang JS. Direct determination of verapamil in rat plasma by coupled column microbore-HPLC method. Journal of Pharmaceutical and Biomedical Analysis 2005; 37(2): 405-410.
16. Koopmans P, Gidding CE, de Graaf SS and Uges DR. An automated method for the bioanalysis of vincristine suitable for therapeutic drug monitoring and pharmacokinetic studies in young children. Therapeutic Drug Monitoring 2001; 23(4): 406-409.
17. Lau-Cam CA and Piemontese D. Simplified reversed-phase HPLC method with spectrophotometic detection for the assay of verapamil in rat plasma. Journal of Pharmaceutical and Biomedical Analysis 1998; 16(6): 1029-1035.
18. Lee JI, Skolnik JM, Barrett JS and Adamson PC. A sensitive and selective liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer. Journal of Mass Spectrometry 2007; 42(6): 761-770.
19. Nelson RL. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer. Medical and Pediatric Oncology 1982; 10(2): 115-127.
20. Rowinsky E and Donhower RC. Antimicrotubule agents. In: Chabner BA and Longo DL (Eds), Cancer Chemotherapy and Biotherapy. Lippincot-Raven: Philadelphia, PA, 1996; 263-275.
21. Sawicki W. A validated method for the determination of verapamil and norverapamil in human plasma. Journal of Pharmaceutical and Biomedical Analysis 2001; 25(3-4): 689-695.
22. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT and Yacobi A. Bioanalytical method validation-a revisit with a decade of progress. Pharmaceutical Research 2000; 17(12): 1551-1557.
23. Skolnik JM, Barrett JS, Shi H and Adamson PC. A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer. Cancer Chemotherapy and Pharmacology 2006; 57 (4): 458-464.
24. Song XR, Cai Z, Zheng Y, He G, Cui FY, Gong DQ, Hou SX, Xiong SJ, Lei XJ and Wei YQ. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. European Journal of Pharmaceutical Sciences 2009; 37(3-4): 300-305.
25. Taylor CW, Dalton WS, Mosley K, Dorr RT and Salmon SE. Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer. Breast Cancer Research and Treatment 1997; 42(1): 7-14.
26. Von Richter O, Eichelbaum M, Schönberger F and Hofmann U. Rapid and highly sensitive method for the determination of verapamil, [2H7] verapamil and metabolites in biological fluids by liquid chromatography-mass spectrometry. Journal of Chromatography B 2000; 738(1): 137-147.